[go: up one dir, main page]

MEP41508A - Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives - Google Patents

Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Info

Publication number
MEP41508A
MEP41508A MEP-415/08A MEP41508A MEP41508A ME P41508 A MEP41508 A ME P41508A ME P41508 A MEP41508 A ME P41508A ME P41508 A MEP41508 A ME P41508A
Authority
ME
Montenegro
Prior art keywords
compounds
formula
cinnamoylaminoalkyl
benzenesulfonamide derivatives
substituted benzenesulfonamide
Prior art date
Application number
MEP-415/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Holger Heitsch
Heinrich Christian Englert
Klaus Wirth
Heinz Goegelein
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MEP41508A publication Critical patent/MEP41508A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MEP-415/08A 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives MEP41508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19923086A DE19923086A1 (de) 1999-05-20 1999-05-20 Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2000/004091 WO2000071513A1 (en) 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Publications (1)

Publication Number Publication Date
MEP41508A true MEP41508A (en) 2011-02-10

Family

ID=7908577

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-415/08A MEP41508A (en) 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Country Status (30)

Country Link
US (1) US6350778B1 (xx)
EP (1) EP1183236B1 (xx)
JP (1) JP4559640B2 (xx)
KR (1) KR100968729B1 (xx)
CN (1) CN1243730C (xx)
AR (1) AR035625A1 (xx)
AT (1) ATE252554T1 (xx)
AU (1) AU771675B2 (xx)
BR (1) BR0010821B1 (xx)
CA (1) CA2374226C (xx)
CZ (1) CZ302943B6 (xx)
DE (2) DE19923086A1 (xx)
DK (1) DK1183236T3 (xx)
EE (1) EE04611B1 (xx)
ES (1) ES2208342T3 (xx)
HK (1) HK1047574B (xx)
HR (1) HRP20010845B1 (xx)
HU (1) HU229041B1 (xx)
IL (2) IL146372A0 (xx)
ME (1) MEP41508A (xx)
MX (1) MXPA01011725A (xx)
NO (1) NO321558B1 (xx)
PL (1) PL201560B1 (xx)
PT (1) PT1183236E (xx)
RS (1) RS50172B (xx)
RU (1) RU2242462C2 (xx)
SK (1) SK287237B6 (xx)
TR (1) TR200103312T2 (xx)
WO (1) WO2000071513A1 (xx)
ZA (1) ZA200109481B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN1237185C (zh) * 2003-06-04 2006-01-18 中国科学院上海药物研究所 Sars冠状病毒3cl蛋白酶三维结构模型与抗sars药物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1518816C3 (de) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE1545810A1 (de) * 1965-05-06 1969-12-11 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
ATE146775T1 (de) * 1993-02-23 1997-01-15 Hoechst Ag Substituierte benzolsulfonylharnstoffe und - thioharnstoffe- verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika
DE4341655A1 (de) 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
JPH0826995A (ja) * 1994-07-22 1996-01-30 Nisshin Flour Milling Co Ltd ベンズイミダゾール誘導体を含有する抗不整脈剤
DE19505397A1 (de) 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
CZ301165B6 (cs) 1998-09-10 2009-11-25 Sanofi - Aventis Deutschland GmbH Použití benzensulfonyl(thio)mocovin pro lécení a profylaxi dysfunkcí autonomní nervové soustavy a použití benzensulfonyl(thio)mocovin v kombinaci s beta-receptorovými blokátory
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors

Also Published As

Publication number Publication date
EE04611B1 (et) 2006-04-17
AU5393300A (en) 2000-12-12
BR0010821A (pt) 2002-03-05
NO321558B1 (no) 2006-05-29
ATE252554T1 (de) 2003-11-15
PL351751A1 (en) 2003-06-16
RS50172B (sr) 2009-05-06
HK1047574A1 (en) 2003-02-28
TR200103312T2 (tr) 2002-04-22
YU81701A (sh) 2004-07-15
HU229041B1 (hu) 2013-07-29
CN1360571A (zh) 2002-07-24
JP4559640B2 (ja) 2010-10-13
KR100968729B1 (ko) 2010-07-08
KR20020005046A (ko) 2002-01-16
CA2374226C (en) 2010-08-31
IL146372A0 (en) 2002-07-25
DE19923086A1 (de) 2000-11-23
ZA200109481B (en) 2002-06-25
HRP20010845A2 (en) 2003-04-30
NO20015636D0 (no) 2001-11-19
HUP0201906A2 (en) 2002-09-28
PL201560B1 (pl) 2009-04-30
AR035625A1 (es) 2004-06-23
AU771675B2 (en) 2004-04-01
HUP0201906A3 (en) 2005-04-28
EP1183236A1 (en) 2002-03-06
BR0010821B1 (pt) 2011-07-12
HRP20010845B1 (en) 2010-08-31
RU2242462C2 (ru) 2004-12-20
EE200100609A (et) 2003-02-17
CA2374226A1 (en) 2000-11-30
CZ302943B6 (cs) 2012-01-25
HK1047574B (zh) 2006-08-04
US6350778B1 (en) 2002-02-26
DE60006104D1 (de) 2003-11-27
IL146372A (en) 2007-05-15
DK1183236T3 (da) 2004-02-23
SK16692001A3 (sk) 2002-04-04
EP1183236B1 (en) 2003-10-22
DE60006104T2 (de) 2004-08-05
MXPA01011725A (es) 2002-04-24
ES2208342T3 (es) 2004-06-16
PT1183236E (pt) 2004-03-31
WO2000071513A1 (en) 2000-11-30
CZ20014149A3 (cs) 2002-03-13
HRP20010845A9 (en) 2010-06-30
SK287237B6 (sk) 2010-04-07
CN1243730C (zh) 2006-03-01
JP2003500388A (ja) 2003-01-07
NO20015636L (no) 2002-01-15

Similar Documents

Publication Publication Date Title
EP1148053A4 (en) 2H-PHTHALAZIN-1-ON DERIVATIVES AND DRUG COMPOSITIONS THAT CONTAIN THESE DERIVATIVES AS ACTIVE INGREDIENTS
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
BR0011938A (pt) Benzenocarbonamidas substituìdas por indanila, processos para a sua preparação, seu emprego como medicamento bem como preparados farmacêuticos contendo as mesmas
DE60109324D1 (de) Acylaminoalkyl-substituierte benzolsulfonamidderivate
TNSN05037A1 (fr) Derives heterobiaryliques servant d'inhibiteurs de metalloproteinases de matrice
BR9914206A (pt) Ceto-amidas heterocìclicas 2-substituìdas úteis para tratar a perda de cabelos em mamìferos
HUP0102602A2 (hu) Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DE69624813T2 (de) Robustaflavon und dessen derivate als antivirales mittel
CA2220533A1 (en) 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
DK1150963T3 (da) Substituerede 4-amino-2-aryltetrahydroquinazoliner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
MEP41508A (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
AR029229A1 (es) Compuestos de piperazina sustituida, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento
RU2225403C2 (ru) Сульфонамидозамещенные бензопирановые производные, способ их получения и фармацевтическая композиция на их основе
SA96160669B1 (ar) علاج مشترك لعدوى فيروس نقص المناعة الذاتية المكتسب للبشر HIV باستخداممثبط الإنزيم protease inhibitor ومثبط الإنزيم الناسخ العكسي reverse transcriptase inhibitor مع AZT
RU2223264C2 (ru) Сульфонамидзамещенные аннелированные семичленные циклические соединения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
MX2009012644A (es) Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden.
RU2223951C2 (ru) Сульфонамидзамещенные анеллированные пятичленные циклические соединения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
HK1113353A1 (en) Piperidinesulfonylureas and-thioureas, their preparation, their use and pharmaceutical compositions comprising them
WO2001062711A3 (en) Substituted alkylene diamine compounds
CA2337397A1 (en) 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
DE3686688T2 (de) Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten.
ATE410414T1 (de) Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
HUP0301971A2 (hu) Taliporfin vagy származékainak alkalmazása szívbetegségek kezelésére szolgáló gyógyászati készítmények elżállítására és a vegyületek